Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
EVH
HOLDEvolent Health, Inc. · Healthcare · United States · $475M · Avg Vol: $12M/d
COMPANY DESCRIPTION
Evolent Health, Inc. provides clinical and administrative solutions that enable healthcare payers and providers to transition to and succeed in value-based care models. The company's proprietary technology platform and clinical care workflows establish a strong competitive moat by deeply integrating into customer operations to manage complex patient populations. It operates as a leading specialty health information services provider with a highly recurring revenue model.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.4B | 2.0B | 2.6B | 1.9B | 11.5% | 1.9B | 2.5B | 2.9B | 25.1% |
| EPS | -0.20 | -1.28 | -0.81 | -5.07 | — | -4.78 | — | — | — |
| Shares | 100.0M | 113.9M | 115.0M | 111.6M | +11.7% | 112.5M | — | — | — |
| Debt | 476.1M | 644.8M | 713.7M | 989.7M | 27.6% | 985.4M | — | — | — |
| Equity | 859.4M | 1.1B | 1.0B | 415.2M | -21.5% | — | — | — | — |
| Op CF | -11.6M | 142.6M | 18.8M | 38.8M | -47.8% | 33.3M | — | — | — |
| Inv CF | -259.1M | -415.5M | -62.9M | -0.2M | — | — | — | — | — |
| Fin CF | 131.5M | 281.3M | -0.6M | -35.9M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of EVH are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| EVH | Evolent Health, Inc.(you) | $475M | 44 | HOLD |
| PHR | Phreesia, Inc. | $632M | 47 | HOLD |
| CTEV | Claritev Corporation | $368M | 40 | HOLD |
| WEAV | Weave Communications, Inc. | $491M | 54 | HOLD |
| MDRX | Veradigm Inc. | $517M | 66 | BUY |
| CERT | Certara, Inc. | $1.2B | 53 | HOLD |
| NRC | NRC Health | $474M | 72 | BUY |
| HCAT | Health Catalyst, Inc. | $154M | 37 | HOLD |
| CARL | Carlsmed, Inc. | $294M | 24 | SELL |
| LFMD | LifeMD, Inc. | $179M | 32 | SELL |
Peer medians: ROE -25.5% · P/E 27.7x · Gross margin 50.7%